Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
332
NCT05320588
A Study in Patients With Advanced Cancers
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 25, 2022
Completion: Apr 30, 2027